UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Compass Wealth Management LLC

Compass Wealth Management LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 31.5% during the third quarter, Holdings Channel reports. The fund owned 150 shares of the healthcare conglomerate’s stock after selling 69 shares during the quarter. Compass Wealth Management LLC’s holdings in UnitedHealth Group were worth $88,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in UNH. Riversedge Advisors LLC acquired a new position in shares of UnitedHealth Group in the third quarter valued at approximately $226,000. Global Retirement Partners LLC grew its stake in UnitedHealth Group by 1.2% in the 3rd quarter. Global Retirement Partners LLC now owns 19,050 shares of the healthcare conglomerate’s stock worth $11,138,000 after acquiring an additional 234 shares during the period. Mitchell & Pahl Private Wealth LLC lifted its stake in shares of UnitedHealth Group by 6.9% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 8,787 shares of the healthcare conglomerate’s stock worth $5,138,000 after purchasing an additional 564 shares during the period. Good Life Advisors LLC increased its stake in UnitedHealth Group by 50.6% in the third quarter. Good Life Advisors LLC now owns 1,545 shares of the healthcare conglomerate’s stock valued at $903,000 after purchasing an additional 519 shares during the last quarter. Finally, Greater Midwest Financial Group LLC boosted its stake in UnitedHealth Group by 0.8% in the 3rd quarter. Greater Midwest Financial Group LLC now owns 4,546 shares of the healthcare conglomerate’s stock worth $2,658,000 after buying an additional 36 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.9 %

Shares of UNH opened at $566.00 on Friday. The stock has a 50-day moving average price of $584.20 and a 200 day moving average price of $533.07. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63. The company has a market capitalization of $522.66 billion, a P/E ratio of 37.53, a P/E/G ratio of 1.69 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the company posted $6.56 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.68 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.48%. UnitedHealth Group’s payout ratio is 55.70%.

Analyst Ratings Changes

Several brokerages have recently weighed in on UNH. Wells Fargo & Company increased their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price objective for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. Truist Financial reiterated a “buy” rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday. Bank of America dropped their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Wednesday. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $615.16.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.